Ftse Mib
34.171,69
0,03%
DAX
19.909,14
-0,25%
S&P 500
5.915,35
-0,93%
NASDAQ
19.461,14
-1,32%
Bitcoin
91.867,21
-1,77%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Genetic Technologies Ltd (GENE) Genetic Technologies Ltd (GENE) Notizie

Genetic Technologies Ltd

GENE
0,765
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/12/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202414:30GLOBEJoin Genetic Technology’s Exclusive Live Investor Webinar..
11/9/202415:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202414:15GLOBEGenetic Technologies Invited to Join Prestigious “CancerIQ”..
28/8/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202414:00GLOBEGenetic Technologies Announces Global Launch of geneType™ on..
09/8/202414:00GLOBEJoin Genetic Technology’s Exclusive Live Investor Webinar..
31/7/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/7/202414:00GLOBEGenetic Technologies Strategic Restructure Driving USA Sales..
16/7/202414:00GLOBEGenetic Technologies Announces Appointment of Chief..
09/7/202414:00GLOBEGeneType to Enter Canadian and New Zealand Markets
25/6/202414:00GLOBEGeneType Identifies 79.5% of People Tested are at Risk of..
21/6/202414:00GLOBEJoin Genetic Technologies’ Exclusive Live Investor Webinar..
18/6/202414:00GLOBEGenetic Technologies Expands Operational Capacity in North..
05/6/202414:00GLOBEGeneType and Stayhealthy Announce Landmark Distribution..
05/6/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202414:00GLOBEGTG Launches Revolutionary geneType Test covering 100% Risk..
29/5/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202414:00GLOBEGeneType and Humanise Health host “Know Your Risk” Event
06/5/202414:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
22/4/202421:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
18/4/202418:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/4/202414:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/4/202414:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/4/202414:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/4/202414:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/4/202414:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/3/202413:00GLOBEGTG Global Collaborations and Innovation Update
25/3/202413:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202414:00GLOBELaunching our most comprehensive test and expanding into new..
09/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
Apertura: Min: Max:
Chiusura: 0,765

La tua Cronologia

NASDAQ
GENE
Genetic Technologies
TSX
TMEC
TD Morningstar ESG Canad...
BFNX
EOSEUR
EOS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network